摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氟-3-羟基苯腈 | 186590-04-5

中文名称
4-氟-3-羟基苯腈
中文别名
4-氟-3-羟基苯甲腈
英文名称
4-fluoro-3-hydroxybenzonitrile
英文别名
——
4-氟-3-羟基苯腈化学式
CAS
186590-04-5
化学式
C7H4FNO
mdl
MFCD08689519
分子量
137.113
InChiKey
LKTBMKIXEOGAGF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    69-72
  • 沸点:
    240.4±25.0℃ (760 Torr)
  • 密度:
    1.34±0.1 g/cm3 (20 ºC 760 Torr)
  • 闪点:
    99.2±23.2℃

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    44
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2926909090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    请保持冷静。

SDS

SDS:e50d432d88f3d788c67808e1b8006444
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Fluoro-3-hydroxybenzonitrile
Synonyms: 2-Fluoro-5-cyanophenol

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Fluoro-3-hydroxybenzonitrile
CAS number: 186590-04-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H4FNO
Molecular weight: 137.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-氟-3-羟基苯腈titanium(IV) isopropylate 、 hydroquinine 1,4-phthalazinediyl diether 、 sodium hexamethyldisilazanepotassium carbonate 作用下, 以 四氢呋喃乙醚N,N-二甲基甲酰胺叔丁醇 为溶剂, 反应 21.5h, 生成 (S)-2-(3-(cyclopropylmethoxy)-4-fluorophenyl)butane-1,2-diol
    参考文献:
    名称:
    [EN] HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
    [FR] HYDANTOÏNE CONTENANT DES INHIBITEURS DE LA DÉSOXYURIDINE TRIPHOSPHATASE
    摘要:
    提供的是dUTPase抑制剂,包括这样的化合物以及使用这些化合物和组合物的方法。
    公开号:
    WO2017006282A1
  • 作为产物:
    描述:
    4-氟-3-甲氧基苯腈lithium chloride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 17.0h, 以38%的产率得到4-氟-3-羟基苯腈
    参考文献:
    名称:
    [EN] FLUOROPHENYL PYRAZOL COMPOUNDS
    [FR] COMPOSÉS FLUOROPHÉNYL-PYRAZOLE
    摘要:
    本发明提供了一种式(I)的化合物,其中X选自(II)组成的群;R选自H和CH3组成的群;R1选自H、CH3、F、Cl、OCH3、C(O)OH、C(O)NH2和(III)组成的群;或其药用可接受的盐。
    公开号:
    WO2015089800A1
点击查看最新优质反应信息

文献信息

  • Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions
    作者:Jaclyn R. Patterson、Lamont R. Terrell、Carla A. Donatelli、Dennis A. Holt、Larry J. Jolivette、Ralph A. Rivero、Theresa J. Roethke、Arthur Shu、Patrick Stoy、Guosen Ye、Mark Youngman、Brian G. Lawhorn
    DOI:10.1021/acs.jmedchem.0c01303
    日期:2020.12.10
    heart failure generated a novel series of acyclic amine inhibitors displaying exceptional potency and PK properties. The series arose through a scaffold hopping approach, which relied on use of an internal H-bond to replace a saturated heterocyclic ring. Optimization of the lead through investigation of both aryl regions revealed approaches to increase potency through substituents believed to enhance separate
    TRPV4作为治疗与心力衰竭相关的肺水肿的潜在靶标的研究产生了一系列新的无环胺抑制剂,这些抑制剂显示出非凡的效能和PK特性。该系列是通过脚手架跳跃方法产生的,该方法依靠内部氢键的使用来取代饱和的杂环。通过研究两个芳基区域对铅进行优化,揭示了通过取代基提高效力的方法,这些取代基被认为可以增强单独的分子内和分子间H键相互作用。通过电子调节苯磺酰胺可稳定胺和相邻苯磺酰胺之间拟议的内部氢键。在芳基醚部分,对位的腈取代基显示出对TRPV4识别的电子作用。最后,
  • [EN] 6-MEMBERED URACIL ISOSTERES<br/>[FR] ISOSTÈRES D'URACILE À 6 CHAÎNONS
    申请人:CV6 THERAPEUTICS NI LTD
    公开号:WO2018098204A1
    公开(公告)日:2018-05-31
    Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    本文件提供了dUTPase抑制剂,包含此类化合物的组合物以及使用此类化合物和组合物的方法。
  • [EN] NITROGEN RING LINKED DEOXYURIDINE TRIPHOSPHATASE INHIBITORS<br/>[FR] INHIBITEURS DE DÉSOXYURIDINE TRIPHOSPHATASE LIÉS À UN CYCLE AZOTE
    申请人:CV6 THERAPEUTICS NI LTD
    公开号:WO2018098208A1
    公开(公告)日:2018-05-31
    Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    本文件提供了dUTPase抑制剂,包含此类化合物的组合物以及使用此类化合物和组合物的方法。
  • [EN] URACIL CONTAINING COMPOUNDS<br/>[FR] COMPOSÉS CONTENANT DE L'URACILE
    申请人:CV6 THERAPEUTICS NI LTD
    公开号:WO2018128720A1
    公开(公告)日:2018-07-12
    Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    提供的是dUTPase抑制剂,包含此类化合物的组合物以及使用此类化合物和组合物的方法。
  • [EN] COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS<br/>[FR] INHIBITEURS DU RÉCEPTEUR DE FACTEUR-1 DE STIMULATION DE COLONIES (CSF-1R)
    申请人:GENZYME CORP
    公开号:WO2017015267A1
    公开(公告)日:2017-01-26
    Compounds of the formulas I and XIII, which are useful as colony stimulating factor-1 receptor inhibitors ("CSF 1R inhibitors").
    I和XIII式化合物,可用作促细胞增殖因子-1受体抑制剂("CSF 1R抑制剂")。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐